NYMOX PHARMACEUTICAL CORPORATION Cash
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Cash of $74.00 thousand as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:Cash · last filed 2025-06-03
- 2024-12-31: Cash $74.00K.
- 2024-09-30: Cash $41.00K.
- 2023-12-31: Cash $70.00K.
- 2023-09-30: Cash $76.00K.
| Period end | Cash |
|---|---|
| 2024-12-31 | $74.00K 20-F · filed 2025-06-03 |
| 2024-09-30 | $41.00K 6-K · filed 2025-01-02 |
| 2023-12-31 | $70.00K 20-F · filed 2025-06-03 |
| 2023-09-30 | $76.00K 6-K · filed 2023-11-15 |
| 2023-06-30 | $132.00K 6-K · filed 2023-08-14 |
| 2023-03-31 | $351.00K 6-K · filed 2023-05-12 |
| 2022-12-31 | $1.40M 20-F · filed 2024-08-29 |
| 2022-09-30 | $2.70M 6-K/A · filed 2022-11-16 |
| 2022-06-30 | $4.07M 6-K · filed 2022-08-15 |
| 2021-12-31 | $830.00K 20-F · filed 2023-05-02 |
| 2020-12-31 | $3.61M 20-F · filed 2022-03-30 |
| 2019-12-31 | $5.24M 20-F · filed 2022-03-30 |